2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
P05.018<br />
screening for cADAsiL in central italian patients<br />
L. Pianese 1 , A. Cappelli 1,2 , M. Scarcella 3 , G. Cacchiò 3 , P. Staffolani 1 , M.<br />
Ragno 3 ;<br />
1 Laboratorio Medicina Molecolare, ASUR ZT13, Ascoli Piceno, Italy, 2 School <strong>of</strong><br />
Advanced Studies: Environmental Sciences and Public Health, Camerino, Italy,<br />
3 U. O. Neurologia, ASUR ZT13, Ascoli Piceno, Italy.<br />
Cerebral autosomal dominant arteriopathy with subcortical infarcts and<br />
leukoencephalopathy (CADASIL) is an inherited autosomal dominant<br />
condition characterized by a variable combination <strong>of</strong> recurrent cerebral<br />
ischemic episodes, cognitive deficits, migraine with aura and psychiatric<br />
symptoms . It results from mutations distributed throughout the<br />
34 EGFRs (epidermal growth factor-like repeats) <strong>of</strong> the Notch3 gene,<br />
leading to the addition or the loss <strong>of</strong> a cysteine residue .<br />
We performed genetic testing for Notch3 mutations in 45 probands<br />
<strong>of</strong> different family with suspected CADASIL who had been referred to<br />
our service in 2007 . DNA samples were analyzed for mutations in all<br />
exons <strong>of</strong> EGFRs using an appropriate screening protocol considering<br />
the mutations distribution in exons gene .<br />
The sequence analysis <strong>of</strong> Notch3 gene revealed the presence <strong>of</strong> three<br />
previously reported missense mutations: C144F in exon 4, G528C in<br />
exon 10 and R1006C in exon 19 . In particular, the mutation C144F was<br />
found in one family, whereas the mutations G528C and R1006C were<br />
found in two and seven families respectively, with the same regional<br />
origin . These results suggest a higher frequency <strong>of</strong> exon 10 and 19<br />
mutations in central Italy and confirm that the genetic procedures could<br />
be optimized by a geographical region-oriented genetic analysis .<br />
We are extending genetic analysis to the remaining exons <strong>of</strong> Notch3<br />
gene in patients with clinical and strumental features more suggestive<br />
<strong>of</strong> CADASIL phenotype, negative for EGFRs mutations .<br />
P05.019<br />
KRIT1 gene mutations in Sardinian patients with cerebral<br />
cavernous malformations<br />
M. A. Melis1 , M. Addis1 , R. Congiu1 , C. Meloni1 , A. Loi2 , M. Melis3 , M. Loi3 , M.<br />
Cau1 ;<br />
1 2 University <strong>of</strong> Cagliari, Cagliari, Italy, Ospedale Regionale per le Microcitemie,<br />
Cagliari, Italy, 3Azienda Ospedaliera Brotzu, Cagliari, Italy.<br />
Cerebral Cavernous Malformations (CCM) are CNS vascular anomalies<br />
associated with seizures, headaches and hemorrhagic strokes and<br />
represents 10 to 20 percent <strong>of</strong> cerebral lesions . CCM is present in 0 .1<br />
to 0 .5 <strong>of</strong> the population . This disorder most <strong>of</strong>ten occurs sporadically<br />
but may also be familial . Familial cases are inherited as a dominant<br />
trait with incomplete penetrance and are estimated to account for 10-<br />
40 % <strong>of</strong> the patients. The identification <strong>of</strong> the genes involved in such<br />
disorders allow to characterize carriers <strong>of</strong> the mutations without clear<br />
symptoms. The first gene involved in CCM1 is KRIT 1. In addition to<br />
KRIT1 two other genes have been described: MGC4607 (CCM2) and<br />
PDCD10 (CCM3) . We selected 14 patients belonging to seven Sardinian<br />
families on the basis <strong>of</strong> clinical symptoms and Magnetic Resonance<br />
results . MLPA analysis <strong>of</strong> KRIT1, MGC4607 and PDCD10 gave<br />
negative results . Sequencing analysis <strong>of</strong> KRIT1 gene was performed<br />
in all the patients. We identified a 4bp deletion in exon 9 leading to a<br />
premature stop codon in a patient with clear phenotype . The same mutation<br />
has been found in three relatives showing very mild symptoms .<br />
In 5 subjects belonging to four unrelated families a unique nonsense<br />
mutation (C329X) has been found . Haplotype analysis in these four<br />
families revealed a common origin <strong>of</strong> the mutation . These data suggest<br />
a “founder effect”, already described in different populations .<br />
P05.020<br />
Functional analysis <strong>of</strong> cD96, a causative gene for a form <strong>of</strong> c<br />
(Opitz trigonocephaly) syndrome<br />
T. Kaname 1,2 , K. Yanagi 1 , Y. Chinen 1 , Y. Makita 3 , N. Okamoto 4 , K. Kurosawa 5 ,<br />
H. Maehara 1 , Y. Fukushima 6 , A. Bohring 7 , J. M. Opitz 8 , K. Yoshiura 9,2 , N. Niikawa<br />
10,2 , K. Naritomi 1,2 ;<br />
1 University <strong>of</strong> the Ryukyus, Nishihara-cho, Japan, 2 SORST, JST, Kawaguchi,<br />
Japan, 3 Asahikawa Medical College, Asahikawa, Japan, 4 Osaka Medical Center<br />
and Research Institute for Maternal and Child Health, Izumi, Japan, 5 Kanagawa<br />
Children’s Medical Center, Yokohama, Japan, 6 Shinshu University School <strong>of</strong><br />
Medicine, Matsumoto, Japan, 7 Westfälische Wilhelms-Universität, Münster,<br />
Germany, 8 University <strong>of</strong> Utah School <strong>of</strong> Medicine, Salt Lake City, UT, United<br />
States, 9 Nagasaki University Graduate School <strong>of</strong> Biomedical Sciences, Na-<br />
gasaki, Japan, 10 Health Sciences University <strong>of</strong> Hokkaido, Tobetsu-cho, Japan.<br />
The C syndrome is characterized by trigonocephaly associated with<br />
unusual facies, psychomotor retardation, redundant skin, joint and<br />
limb abnormalities, and visceral anomalies . In an individual with<br />
the C syndrome harboring a balanced chromosomal translocation,<br />
t(3;18)(q13.13;q12.1), we identified a gene (CD96), which encodes<br />
a member <strong>of</strong> the immunoglobulin superfamily, was disrupted at the<br />
3q13 .3 breakpoint . In mutation analysis <strong>of</strong> karyotypically normal patients<br />
with the C or C-like syndromes, we identified a missense mutation<br />
in exon 6 <strong>of</strong> the CD96 gene in one patient and found reduced expression<br />
in two patients . In order to know the function <strong>of</strong> CD96, we established<br />
normal CD96 or the mutated CD96 expressed cell lines and<br />
investigated their characters especially on cell-adhesion activity and<br />
cell-growth activity . Cells with the normal CD96 protein increased both<br />
the cell-adhesion and growth activities compared with MOCK cells . On<br />
the other hand, cells with the mutated CD96 protein lost the activities in<br />
vitro. These findings may indicate that CD96 mutations cause a form <strong>of</strong><br />
the C syndrome by interfering with cell adhesion and growth .<br />
P05.021<br />
Evidence on microRNA-mediated regulation <strong>of</strong> CDK5R1 gene<br />
expression<br />
S. Moncini 1 , M. Venturin 1 , A. Salvi 2 , V. Lanzi 1 , C. Sabelli 2 , G. De Petro 2 , S.<br />
Barlati 2 , P. Riva 1 ;<br />
1 University <strong>of</strong> Milan, Milan, Italy, 2 University <strong>of</strong> Brescia, Brescia, Italy.<br />
CDK5R1 encodes for p35, an activator <strong>of</strong> CDK5, which is involved<br />
in neuronal migration and differentiation during central nervous system<br />
development and has been candidated for mental retardation .<br />
We recently reported that the large 3’ untranslated region (3’UTR) <strong>of</strong><br />
CDK5R1 contains regulatory elements affecting transcript stability .<br />
Besides several AREs, many microRNAs (miRNAs) target sites have<br />
been predicted by PicTar s<strong>of</strong>tware . We evaluated the expression <strong>of</strong><br />
nine pre-miRNAs, among the 20 miRNAs predicted to bind CDK5R1,<br />
in six cell lines, including two neuroblastoma derived lines . Among the<br />
expressed miRNAs, we observed that miR-15a, miR-103 and miR-<br />
107 presented a high number <strong>of</strong> target sites with a free energy